STEWARD CARNEY HOPSITAL — History
CCN 220017 | 3-year financial timeline | COVID resilience: 45/100
🛡️ Public data only — no PHI permitted on this instance.
$92M
Latest Revenue (FY2022)
-6.3%
Revenue CAGR (3yr)
-46.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $105M | $92M | $92M | +0.7% | -6.3% |
| Operating Expenses | $156M | $130M | $135M | +3.9% | -7.0% |
| Operating Margin | -48.9% | -42.0% | -46.6% | -10.9% | +0.0% |
| Net Income | $-51M | $-38M | $-43M | -11.7% | +0.0% |
| Licensed Beds | 106 | 106 | 106 | +0.0% | +0.0% |
| Total Patient Days | 23,647 | 20,760 | 19,796 | -4.6% | -8.5% |
| Medicare Day % | 24% | 22% | 19% | -10.1% | -10.7% |
| Medicaid Day % | 13% | 15% | 33% | +124.7% | +58.0% |
COVID Impact & Recovery
Resilience Score: 45/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -12.2% ($105M → $92M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-6.3%
This Hospital
+7.6%
State Avg
Latest Margin
-46.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $86M | -45.5% |
| FY2024 (proj) | $79M | -44.3% |
| FY2025 (proj) | $73M | -43.2% |